Robot Mends Hearts in Britain

A remote-controlled robot helps British surgeons repair heart defects.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wikimedia, NIHSurgeons at the New Cross Hospital in Wolverhampton, United Kingdom, performed the country’s first robotic-assisted heart surgeries using a $1.6 million remote-controlled robot, called Da Vinci, according to a news story published yesterday (October 22) by the BBC. In one of the robot-assisted surgeries, a young woman, Natalie Jones of Stourbridge, had a 1.3-inch hole repaired in her heart. In a second surgery, the robot repaired the valve between the left atrium and ventricle of a middle-aged man, Paul Whitehouse from Halesowen.

Finland and Sweden are the only other countries in Europe to perform robotic heart surgery, while surgeons in America performed their first robot-assisted heart surgery in 1999.

While conventional heart surgery requires opening the whole breastplate, surgery using Da Vinci requires only incisions between the ribs, and doctors say the surgery over-all is safer and the patients recover faster. “There is less pain and patients are able to return home to their normal activities far sooner,” heart surgeon Stephen Billing, who was involved in both surgeries, told the BBC. The remote-controlled robot can make precise motions—moving just 1 mm for every 3 mm that the doctors move their hands—and surgeons have a 3-dimensional view of a patient’s heart throughout the procedure.

But, robotic surgery comes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies